Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom

PURPOSE: To report the 12-months visual and anatomical outcomes of chronic diabetic macular oedema (DMO) treated with ILUVIEN in a real-world clinical practice in a single tertiary referral centre. METHOD: Retrospective data collection and analysis of consecutive 28 eyes of 23 diabetic patients rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfaqawi, F, Lip, P L, Elsherbiny, S, Chavan, R, Mitra, A, Mushtaq, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396008/
https://www.ncbi.nlm.nih.gov/pubmed/28106887
http://dx.doi.org/10.1038/eye.2016.301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396008/
https://www.ncbi.nlm.nih.gov/pubmed/28106887
http://dx.doi.org/10.1038/eye.2016.301

Ejemplares similares